Schizophrenia Schizoaffective Clinical Trial
Official title:
Testing the Feasibility and Acceptability of a New Personalised Form of Cognitive Remediation Therapy (pCRT) for People With Psychosis.
Cognitive deficits have been shown to have negative impact on social functioning and
functional goals such as ability to work and perform daily tasks in people with
schizophrenia. There is evidence that Cognitive Remediation Therapy, a form of psychological
therapy, is effective in improving cognition and functioning but there is still a limited
understanding of what influence people's different response to this therapy. A tailored
treatment is likely to be more effective because it will adapt to service users' unique
characteristics.
The investigators are planning a study exploring at the feasibility and acceptability of
novel form of Cognitive Remediation Therapy which is personalised (pCRT) to the person
individual characteristics. The personalised therapy will consist of task practice using
computerized Cognitive Remediation software (i.e. called CIRCuiTS). The knowledge gathered in
this work will contribute to develop the next generation of personalised treatment approaches
for people with schizophrenia.
Cognitive deficits in people with psychosis have been shown to have negative impact on functional goals including the ability to work and perform daily tasks. Cognitive Remediation Therapy (CRT) is a psychological therapy developed to improve cognitive functions in people with schizophrenia but ultimately with a focus on improving social and functional outcomes. There is evidence that CRT is effective in improving cognition and functioning but there is still a limited understanding of the mechanisms responsible for different treatment responses. This study attempts to fill this gap by developing and testing a new form of CRT, which will personalise therapy elements according to participants' characteristics. The therapy will consist of task practice using a computerised Cognitive Remediation software and supervised activities supported by a therapist to boost functioning. The knowledge gathered in this work will contribute to develop the next generation of personalised treatment approaches for people with schizophrenia. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05414058 -
Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes
|
Phase 2 | |
Recruiting |
NCT05660018 -
TMS Related Biomarker Assessments
|
N/A | |
Not yet recruiting |
NCT06275451 -
Qualitative Study of Emotional Regulation in Schizophrenia
|
||
Active, not recruiting |
NCT04325386 -
Clozapine CHAMPION-ECHO Educational Study to Improve Clozapine Use.
|
N/A | |
Completed |
NCT04567524 -
A Multiple Dose Study to Assess the Safety, Tolerability and PK of Risperidone Extended Release Capsules
|
Phase 2 | |
Recruiting |
NCT05643196 -
Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia
|
Phase 2 |